306 related articles for article (PubMed ID: 36670980)
1. Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury.
de Los Ríos C; Viejo L; Carretero VJ; Juárez NH; Cruz-Martins N; Hernández-Guijo JM
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36670980
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration.
Clark AR; Ohlmeyer M
Pharmacol Ther; 2019 Sep; 201():181-201. PubMed ID: 31158394
[TBL] [Abstract][Full Text] [Related]
3. Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia.
Arriazu E; Pippa R; Odero MD
Front Oncol; 2016; 6():78. PubMed ID: 27092295
[TBL] [Abstract][Full Text] [Related]
4. PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation.
Yang W; Wang X; Liu J; Duan C; Gao G; Lu L; Yu S; Yang H
Oncotarget; 2018 Jan; 9(1):37-53. PubMed ID: 29416594
[TBL] [Abstract][Full Text] [Related]
5. Deletion of a Neuronal Drp1 Activator Protects against Cerebral Ischemia.
Flippo KH; Lin Z; Dickey AS; Zhou X; Dhanesha NA; Walters GC; Liu Y; Merrill RA; Meller R; Simon RP; Chauhan AK; Usachev YM; Strack S
J Neurosci; 2020 Apr; 40(15):3119-3129. PubMed ID: 32144179
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
8. Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia/reperfusion injury.
Stockwell J; Chen Z; Niazi M; Nosib S; Cayabyab FS
Neuropharmacology; 2016 Mar; 102():254-65. PubMed ID: 26626486
[TBL] [Abstract][Full Text] [Related]
9. From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.
Ciccone M; Calin GA; Perrotti D
Front Oncol; 2015; 5():21. PubMed ID: 25763353
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A restrains DLK signaling to promote proper Drosophila synaptic development and mammalian cortical neuron survival.
Hayne M; DiAntonio A
Neurobiol Dis; 2022 Feb; 163():105586. PubMed ID: 34923110
[TBL] [Abstract][Full Text] [Related]
11. Direct Interaction of PP2A Phosphatase with GABA
Li X; Terunuma M; Deeb TG; Wiseman S; Pangalos MN; Nairn AC; Moss SJ; Slesinger PA
J Neurosci; 2020 Apr; 40(14):2808-2816. PubMed ID: 32111696
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A dysfunction in Alzheimer's disease.
Sontag JM; Sontag E
Front Mol Neurosci; 2014; 7():16. PubMed ID: 24653673
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.
Grech G; Baldacchino S; Saliba C; Grixti MP; Gauci R; Petroni V; Fenech AG; Scerri C
Tumour Biol; 2016 Sep; 37(9):11691-11700. PubMed ID: 27444275
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effect of Protein Phosphatase 2A/Tristetraprolin Following Subarachnoid Hemorrhage in Rats.
Yin J; Li R; Liu W; Chen Y; Zhang X; Li X; He X; Duan C
Front Neurosci; 2018; 12():96. PubMed ID: 29535596
[TBL] [Abstract][Full Text] [Related]
16. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
Arribas RL; Viejo L; Bravo I; Martínez M; Ramos E; Romero A; García-Frutos EM; Janssens V; Montiel C; de Los Ríos C
Eur J Med Chem; 2023 May; 251():115245. PubMed ID: 36905916
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.
Cacabelos R; Alvarez A; Lombardi V; Fernández-Novoa L; Corzo L; Pérez P; Laredo M; Pichel V; Hernández A; Varela M; Figueroa J; Prous J; Windisch M; Vigo C
Drugs Today (Barc); 2000 Jul; 36(7):415-99. PubMed ID: 12861345
[TBL] [Abstract][Full Text] [Related]
18. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypoxia on protein phosphatase 2A activity, subcellular distribution and expression in cerebral cortex of newborn piglets.
Truttmann AC; Ashraf Q; Mishra OP; Delivoria-Papadopoulos M
Neuroscience; 2004; 127(2):355-63. PubMed ID: 15262326
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
